Skip to content

Snow Physical Properties and Human Ventilatory Response

Evaluation of Air Pocket Factors That Contribute to the Development of Hypoxia and Hypercapnia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03082105
Enrollment
12
Registered
2017-03-17
Start date
2013-12-01
Completion date
2014-03-09
Last updated
2017-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Avalanche Burial, Hypercapnic Respiratory Failure, Hypoxic Respiratory Failure, Snow Physical Properties

Brief summary

Sufficient oxygenation is critical for completely buried avalanche victims to avoid life-threatening consequences during hypoxic exposure. Snow contains a remarkable capacity to maintain air availability; it was suspected that the snow physical properties affect the development of hypoxia and hypercapnia. The aim of this study was to evaluate the influence of different snow physical properties on the development of hypoxia and hypercapnia in subjects breathing into an artificial air pocket in snow. Twelve male healthy subjects breathed through an airtight face-mask and 40cm tube into an artificial air pocket of 4L. Every subject performed three tests on different days with varying snow characteristics. Symptoms, gas and cardiovascular parameters were monitored up to 30min. Tests were interrupted at SpO2 \<75% (primary endpoint); or due to subjective symptoms like dyspnea, dizziness, and headache (i.e. related to hypercapnia). Snow density was assessed via standard methods and micro-computed tomography (CT) analysis, and permeability and penetration with the snow micro-penetrometer (SMP).

Interventions

OTHERBreathing in snow

Breathing in snow with different physical properties

Sponsors

Medical University Innsbruck
CollaboratorOTHER
Institute of Mountain Emergency Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Healthy volunteers with an age above 18yr-old, physically active. * Volunteers have been informed and have signed consent.

Exclusion criteria

* Lack of consent. * Chronic previous illness of the respiratory tract or of the cardiovascular system. * Acute disease at or immediately prior to the test (eg, flu-like infection, fever of unknown origin). * Eurac employees.

Design outcomes

Primary

MeasureTime frameDescription
SpO2 (%)Changes from baseline (measurement at 0min) -> snow-breathing phase (5min, 15min, and timepoint immediately before interruption of snow-breathing phase [max 30min]) -> 2.5min and 5min after snow-breathing phaseContinuous monitoring

Secondary

MeasureTime frameDescription
EtCO2 (mmHg)Changes from baseline (measurement at 0min) -> snow-breathing phase (5min, 15min, and timepoint immediately before interruption of snow-breathing phase [max 30min]) -> 2.5min and 5min after snow-breathing phaseContinuous monitoring
Cause of interruptionTimepoint immediately before interruption of snow-breathing phase (max 30min)SpO2 \<75% or subjectives symptoms due to hypercapnia (like dyspnea, dizziness, and headache)
VE (L/min)Changes from baseline (measurement at 0min) -> snow-breathing phase (5min, 15min, and timepoint immediately before interruption of snow-breathing phase [max 30min]) -> 2.5min and 5min after snow-breathing phaseContinuous monitoring
rSO2 (%)Changes from baseline (measurement at 0min) -> snow-breathing phase (5min, 15min, and timepoint immediately before interruption of snow-breathing phase [max 30min]) -> 2.5min and 5min after snow-breathing phaseContinuous monitoring

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026